Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Status:
Completed

Trial end date:
2020-03-30

Target enrollment:

Participant gender:

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with DD-CKD

Phase 3

Akebia Therapeutics

Darbepoetin alfa